VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Env from strain FRA

Gene Name Env from strain FRA
Sequence Strain (Species/Organism) Feline leukemia virus
VO ID VO_0011068
NCBI Gene ID 1491868
NCBI Protein GI 9630709
Locus Tag FeLVgp2
Genbank Accession AF052723
Protein Accession NP_047256
Taxonomy ID 11768
Gene Starting Position 5987
Gene Ending Position 7915
Gene Strand (Orientation) ?
Protein Name Env polyprotein
Protein pI 8.36
Protein Weight 67586.88
Protein Length 642
DNA Sequence
>NC_001940.1:5987-7915 Feline leukemia virus, complete genome
GATGGAAAGTCCAACGCACCCAAAACCCTCTAAAGATAAGACTCTCTCGTGGAACTTAGCGTTTCTGGTG
GGGATCTTATTCACAATAGACATAGGAATGGCCAATCCTAGTCCACACCAAATATATAATGTAACTTGGG
TAATAACCAATATGCAAACTAACACCCAAGCTAATGCCACCTCTATGTTAGGAACCTTAACCGATGCCTA
CCCTACCCTACATGTTGACCTATGTGACCTAGTGGGAGACACCTGGGAACCTATAGTCCTAGATCCAACC
AATGTAAAACACGGGGCACGTTACTCCTCCTCAAAGTATGGATGTAAAACTACAGATAGAAAAAAACAGC
AACAAACATACCCCTTTTACGTCTGCCCCGGACATGCCCCCTCGCTGGGGCCAAAGGGAACACATTGTGG
AGGGGCACAAGATGGGTTTTGTGCCGCATGGGGATGTGAGACCACCGGAGAAGCTTGGTGGAAGCCCTCC
TCCTCATGGGACTATATCACAGTAAAAAGAGGGAGTAGTCAGGACAATAGCTGTGAGGGAAAATGCAACC
CCCTGATTTTGCAGTTCACCCAGAAGGGAAGACAAGCCTCTTGGGACGGACCTAAGATATGGGGATTGCG
ACTATACCGTACAGGATATGACCCTATCGCCTTATTCACGGTGTCCCGGCAGGTGTCAGCCATTACGCCG
CCTCAGGCAATGGGACCAAACCTAGTCTTACCTGATCAAAAACCCCCATCCAGACAATCCCAAACAGGGT
CCAAAGTGGCGACCCAGAGGCTCCAAACGACTGAAAGCGCCCCAAGGTCTGTTGCCCCCACCACCGTGGG
TCCCAAACGGATTGGGACCGGAGATAGGTTAATAAATTTAGTACAAGGGACATACCTAGCCTTAAATGCC
ACCGACCCCAACAAAACTAAAGACTGTTGGCTCTGCCTGGTTTCTCGACCACCCTATTACGAAGGGATTG
CAATCTTAGGTAACTACAGCAACCAAACAAACCCCCCCCCATCCTGCCTATCTACTCCGCAACACAAACT
GACCATATCTGAAGTATCAGGGCAAGGACTGTGCATAGGGACTGTTCCTAAGACCCACCAGGCTTTGTGC
AATGAGACACAACAGGGACATACAGGGGCGCACTATCTAGCCGCCCCCAATGGCGCCTATTGGGCCTGTA
ACACTGGACTCACCCCATGCATTTCCATGGCGGTGCTCAATTGGACCTCTGATTTTTGTGTCTTAATCGA
ATTATGGCCCAGAGTGACTTACCATCAACCCGAATATGTGTACACACATTTTGCCAAAGCTGTCAGGTTC
CGAAGAGAACCAATATCACTAACTGTTGCCCTCATGTTGGGAGGACTCACTGTAGGGGGCATAGCCGCGG
GGGTCGGAACAGGGACTAAAGCCCTCCTTGAAACAGCCCAGTTCAGACAACTACAAATGGCCATGCACAC
AGACATCCAGGCCCTAGAAGAGTCAATTAGTGCCTTAGAAAAGTCCCTGACCTCCCTTTCTGAAGTAGTC
TTACAAAACAGACGGGGCCTAGATATTCTATTCTTACAAGAGGGAGGGCTCTGTGCCGCATTAAAAGAAG
AATGTTGCTTCTATGCGGATCACACCGGACTCGTCCGAGACAATATGGCTAAATTGAGAGAAAGACTAAA
ACAGCGGCAACAACTGTTTGACTCCCAACAGGGATGGTTTGAAGGATGGTTCAACAAGTCCCCCTGGTTC
ACAACCTTAATTTCCTCCATTATGGGCCCCTTACTAATCCTACTCCTAATTCTCCTCTTCGGCCCATGCA
TCCTTAACAGATTAGTACAATTCGTAAAAGACAGAATATCTGTGGTACAAGCCTTAATTTTAACCCAACA
GTACCAACAGATAAAGCAATACGATCCGGACCGACCATG

Protein Sequence
>NP_047256.1 Env polyprotein [Feline leukemia virus]
MESPTHPKPSKDKTLSWNLAFLVGILFTIDIGMANPSPHQIYNVTWVITNMQTNTQANATSMLGTLTDAY
PTLHVDLCDLVGDTWEPIVLDPTNVKHGARYSSSKYGCKTTDRKKQQQTYPFYVCPGHAPSLGPKGTHCG
GAQDGFCAAWGCETTGEAWWKPSSSWDYITVKRGSSQDNSCEGKCNPLILQFTQKGRQASWDGPKIWGLR
LYRTGYDPIALFTVSRQVSAITPPQAMGPNLVLPDQKPPSRQSQTGSKVATQRLQTTESAPRSVAPTTVG
PKRIGTGDRLINLVQGTYLALNATDPNKTKDCWLCLVSRPPYYEGIAILGNYSNQTNPPPSCLSTPQHKL
TISEVSGQGLCIGTVPKTHQALCNETQQGHTGAHYLAAPNGAYWACNTGLTPCISMAVLNWTSDFCVLIE
LWPRVTYHQPEYVYTHFAKAVRFRREPISLTVALMLGGLTVGGIAAGVGTGTKALLETAQFRQLQMAMHT
DIQALEESISALEKSLTSLSEVVLQNRRGLDILFLQEGGLCAALKEECCFYADHTGLVRDNMAKLRERLK
QRQQLFDSQQGWFEGWFNKSPWFTTLISSIMGPLLILLLILLFGPCILNRLVQFVKDRISVVQALILTQQ
YQQIKQYDPDRP

Molecule Role Protective antigen
Molecule Role Annotation Study describes experiments which demonstrate that the vaccine, (EURIFEL FeLV; Merial) that expresses the FeLV env and gag protective genes, is effective against any oronasal FeLV challenge. The protection was shown to be solid against an oronasal challenge one year after the initial vaccination, and was effective against a very severe 'in-contact' challenge (Poulet et al., 2003).
Related Vaccines(s) EURIFEL FeLV
References